143 related articles for article (PubMed ID: 38470216)
1. Impact of clonal hematopoiesis of indeterminate potential on hepatocellular carcinoma in individuals with steatotic liver disease.
Marchetti A; Pelusi S; Marella A; Malvestiti F; Ricchiuti A; Ronzoni L; Lionetti M; Moretti V; Bugianesi E; Miele L; Vespasiani-Gentilucci U; Dongiovanni P; Federico A; Soardo G; D'Ambrosio R; McCain MV; Reeves HL; La Mura V; Prati D; Bolli N; Valenti L;
Hepatology; 2024 Mar; ():. PubMed ID: 38470216
[TBL] [Abstract][Full Text] [Related]
2. Familial coaggregation of MASLD with hepatocellular carcinoma and adverse liver outcomes: Nationwide multigenerational cohort study.
Ebrahimi F; Hagström H; Sun J; Bergman D; Shang Y; Yang W; Roelstraete B; Ludvigsson JF
J Hepatol; 2023 Dec; 79(6):1374-1384. PubMed ID: 37647992
[TBL] [Abstract][Full Text] [Related]
3. Association of Clonal Hematopoiesis of Indeterminate Potential With Inflammatory Gene Expression in Patients With Severe Degenerative Aortic Valve Stenosis or Chronic Postischemic Heart Failure.
Abplanalp WT; Mas-Peiro S; Cremer S; John D; Dimmeler S; Zeiher AM
JAMA Cardiol; 2020 Oct; 5(10):1170-1175. PubMed ID: 32639511
[TBL] [Abstract][Full Text] [Related]
4. Chronic Viral Hepatitis B and C Outweigh MASLD in the Associated Risk of Cirrhosis and HCC.
Lee MH; Chen YT; Huang YH; Lu SN; Yang TH; Huang JF; Yin SC; Yeh ML; Huang CF; Dai CY; Chuang WL; Yu ML; Yang HI; Chen HY; Chen CJ
Clin Gastroenterol Hepatol; 2024 Jun; 22(6):1275-1285.e2. PubMed ID: 38365094
[TBL] [Abstract][Full Text] [Related]
5. Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease.
Gumuser ED; Schuermans A; Cho SMJ; Sporn ZA; Uddin MM; Paruchuri K; Nakao T; Yu Z; Haidermota S; Hornsby W; Weeks LD; Niroula A; Jaiswal S; Libby P; Ebert BL; Bick AG; Natarajan P; Honigberg MC
J Am Coll Cardiol; 2023 May; 81(20):1996-2009. PubMed ID: 37197843
[TBL] [Abstract][Full Text] [Related]
6. Steatotic liver disease predicts cardiovascular disease and advanced liver fibrosis: A community-dwelling cohort study with 20-year follow-up.
Choe HJ; Moon JH; Kim W; Koo BK; Cho NH
Metabolism; 2024 Apr; 153():155800. PubMed ID: 38266957
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular Disease Among Patients With AML and CHIP-Related Mutations.
Calvillo-Argüelles O; Schoffel A; Capo-Chichi JM; Abdel-Qadir H; Schuh A; Carrillo-Estrada M; Liu S; Gupta V; Schimmer AD; Yee K; Shlush LI; Natarajan P; Thavendiranathan P
JACC CardioOncol; 2022 Mar; 4(1):38-49. PubMed ID: 35492819
[TBL] [Abstract][Full Text] [Related]
8. Pathology and Pathogenesis of Metabolic Dysfunction-Associated Steatotic Liver Disease-Associated Hepatic Tumors.
Takahashi Y; Dungubat E; Kusano H; Fukusato T
Biomedicines; 2023 Oct; 11(10):. PubMed ID: 37893134
[TBL] [Abstract][Full Text] [Related]
9. Metabolic dysfunction-associated steatotic liver disease increases hepatocellular carcinoma risk in chronic hepatitis B patients: a retrospective cohort study.
Lin M; Gao B; Peng M; Chen X; Xiao H; Shi M; Zhang X; Zeng F; Chi X
Front Physiol; 2024; 15():1347459. PubMed ID: 38405121
[No Abstract] [Full Text] [Related]
10. Clonal hematopoiesis of indeterminate potential in patients with acute coronary syndrome undergoing percutaneous coronary intervention in the absence of traditional risk factors.
Jiang Z; Li Y; Yan C; Zhang X; Zhang Q; Li J; Tian X; Qiu M; Liang Z; Ma S; Na K; Li Z; Chen S; Zhao Y; Qi Z; Liu X; Han Y
Clin Res Cardiol; 2023 Apr; 112(4):506-517. PubMed ID: 35704087
[TBL] [Abstract][Full Text] [Related]
11. EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD).
; ; ;
J Hepatol; 2024 Jun; ():. PubMed ID: 38851997
[TBL] [Abstract][Full Text] [Related]
12. Long-term Risks of Cirrhosis and Hepatocellular Carcinoma Across Steatotic Liver Disease Subtypes.
Chen YT; Chen TI; Yang TH; Yin SC; Lu SN; Liu XR; Gao YZ; Lin CJ; Huang CW; Huang JF; Yeh ML; Huang CF; Dai CY; Chuang WL; Yang HI; Yu ML; Lee MH
Am J Gastroenterol; 2024 Apr; ():. PubMed ID: 38534155
[TBL] [Abstract][Full Text] [Related]
13. Clonal haematopoiesis of indeterminate potential and atrial fibrillation: an east Asian cohort study.
Ahn HJ; An HY; Ryu G; Lim J; Sun C; Song H; Choi SY; Lee H; Maurer T; Nachun D; Kwon S; Lee SR; Lip GYH; Oh S; Jaiswal S; Koh Y; Choi EK
Eur Heart J; 2024 Mar; 45(10):778-790. PubMed ID: 38231881
[TBL] [Abstract][Full Text] [Related]
14. Clonal hematopoiesis of indeterminate potential (CHIP) and cardiovascular diseases-an updated systematic review.
Senguttuvan NB; Subramanian V; Venkatesan V; Muralidharan TR; Sankaranarayanan K
J Genet Eng Biotechnol; 2021 Jul; 19(1):105. PubMed ID: 34279740
[TBL] [Abstract][Full Text] [Related]
15. Phenotypes of Metabolic Dysfunction-Associated Steatotic Liver Disease-Associated Hepatocellular Carcinoma.
Rivera-Esteban J; Muñoz-Martínez S; Higuera M; Sena E; Bermúdez-Ramos M; Bañares J; Martínez-Gomez M; Cusidó MS; Jiménez-Masip A; Francque SM; Tacke F; Minguez B; Pericàs JM
Clin Gastroenterol Hepatol; 2024 Apr; ():. PubMed ID: 38604295
[TBL] [Abstract][Full Text] [Related]
16. Liver and atherosclerotic risks of patients with cryptogenic steatotic liver disease.
Wang SW; Hsieh TH; Cheng YM; Wang CC; Kao JH
Hepatol Int; 2024 Jun; 18(3):943-951. PubMed ID: 38227142
[TBL] [Abstract][Full Text] [Related]
17. Combined effect of histological findings and diabetes mellitus on liver-related events in patients with metabolic dysfunction-associated steatotic liver disease.
Shiomi A; Miyake T; Furukawa S; Matsuura B; Yoshida O; Watanabe T; Kanamoto A; Miyazaki M; Nakaguchi H; Tokumoto Y; Hirooka M; Abe M; Hiasa Y
Hepatol Res; 2024 Apr; ():. PubMed ID: 38656764
[TBL] [Abstract][Full Text] [Related]
18. Histidine-rich glycoprotein in metabolic dysfunction-associated steatohepatitis-related disease progression and liver carcinogenesis.
Foglia B; Sutti S; Cannito S; Rosso C; Maggiora M; Casalino A; Bocca C; Novo E; Protopapa F; Ramavath NN; Provera A; Gambella A; Bugianesi E; Tacke F; Albano E; Parola M
Front Immunol; 2024; 15():1342404. PubMed ID: 38469298
[TBL] [Abstract][Full Text] [Related]
19. Clonal hematopoiesis and associated diseases: A review of recent findings.
Asada S; Kitamura T
Cancer Sci; 2021 Oct; 112(10):3962-3971. PubMed ID: 34328684
[TBL] [Abstract][Full Text] [Related]
20. Cardiometabolic risk factors in MASLD patients with HCC: the other side of the coin.
Meroni M; Longo M; Dongiovanni P
Front Endocrinol (Lausanne); 2024; 15():1411706. PubMed ID: 38846491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
